期刊文献+

不同浓度常用化疗药物连续刺激对人肺腺癌细胞株增殖耐药产生的影响 被引量:2

Effects of repeated treatment with different concentrations of chemotherapy drugs on proliferation and chemo-resistance in human lung cancer cell line
暂未订购
导出
摘要 目的 :探讨常用化疗药物连续刺激对肿瘤细胞株增殖及耐药相关蛋白的影响。 方法 :人肺腺癌细胞株 (L TEP- a- 2 )经多柔比星 (阿霉素 ,ADM)、依托泊苷 (VP- 1 6 )、顺铂 (DDP)单药及联合用药连续刺激 ,每种药物分 2个剂量梯度 ,记录细胞每次刺激间隔的时间。应用流式细胞术分别检测 erb B- 2、c- m yc、MDR1、MRP、L RP、ref- 1和 NF- κB的阳性细胞数及平均荧光强度 ,以此推算出不同药物在不同浓度下连续 2~ 3次作用细胞株后以上各蛋白表达的细胞数、平均表达量、总表达量 ,同时设对照组。结果 :随着培养时间的延长 ,各项检测指标的阳性细胞的百分数、平均荧光强度及总荧光强度均呈下降趋势。高剂量各组上述各项指标基本上均随刺激次数的增加呈下降趋势 ,而低剂量各组的检测指标则有升有降 ,无一定规律 ,而 erb B- 2、MDR1、ref- 1和 NF-κB增高。 结论 :小剂量化疗药物连续刺激比大剂量更易诱导肿瘤细胞增殖以及耐药的形成 。 Objective:To explore the variation of tumor cell proteins correlated with cell proliferation and chemo-resis-tance after repeated treatment with chemotherapy drugs.Methods:The human lung cancer cell line(LPET-a-2)was repeat-edly treated with chemotherapy drugs:doxorubicin,etoposide,cisplatin and the combination of the3drugs,and each drug was given at2concentrations.The treatment intervals were recorded.ErbB-2,c-myc,MDR1,MRP,LRP,ref-1and NF-κB were tested by flow cytometry.The cells expressing each protein,the mean and total quantity of each protein after each treat-ment were calculated by different drugs at different concentrations.Results:The levels of every protein decreased along with the time of culture.In high-dose group,every item decreased along with the time of treatment.In low-dose group,there was no rule for the item variation with some decreased and some increased.Conclusion:Low-dose anticancer drugs are easier to induce cell proliferation and chemo-resistance than high-dose one,which suggests that adequate chemotherapy should be given in clinical practice.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2004年第7期781-784,共4页 Academic Journal of Second Military Medical University
关键词 肺肿瘤 流式细胞术 细胞增殖 抗药性 肿瘤 lung neoplasms flow cytometry cell proliferation drug resistance,neoplasm
  • 相关文献

参考文献11

  • 1Kim KB, Lotan R, Yue P, et al. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells[J]. Mol Cancer Ther, 2002, 1(3):177-184.
  • 2Ma C, Lin H, Leonard SS, et al. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro[J]. Oncogene, 2003, 22(34):5281-5290.
  • 3Alaoui-Jamali MA, Paterson J, Al Moustafa AE, et al. The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications[J]. Biochem Cell Biol, 1997, 75(4): 315-325.
  • 4Hapke S, Kessler H, Luber B, et al. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction[J]. Biol Chem, 2003, 384(7):1073-1083.
  • 5Rittierodt M, Harada K. Repetitive doxorubicin treatment of glioblastoma enhances the PGP expression-a special role for endothelial cells[J]. Exp Toxicol Pathol, 2003, 55(1): 39-44.
  • 6Itamochi H, Kigawa J, Sultana H, et al. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary[J]. Jpn J Cancer Res, 2002, 93(6):723-728.
  • 7Sunnaram BL, Gandemer V, Sebillot M, et al. LRP overexpression in monocytic lineage[J]. Leuk Res, 2003, 27(8):755-759.
  • 8Thomson B, Tritt R, Davis M, et al. Histology-specific expression of a DNA repair process in pediatric rhabdomyosarcomas[J]. J Pediatr Hematol Oncol, 2001, 23(4):234-239.
  • 9Lu Y, Zi X, Zhao Y, et al. Insulin-like growth factor-Ⅰ receptor signaling and resistance to trastuzumab (Herceptin) [J]. J Natl Cancer Inst, 2001 , 93(24): 1852-1857.
  • 10黄守国,孔北华,马玉燕,江森.三氧化二砷对人卵巢癌耐药细胞株细胞增殖和转移能力的影响[J].癌症,2002,21(8):863-867. 被引量:39

二级参考文献6

共引文献39

同被引文献9

  • 1赵永新,徐乃焕.注射剂临床使用有关事宜[J].中南药学,2004,2(6):374-376. 被引量:9
  • 2金有豫.药理学[M](第5版)[M].北京:人民卫生出版社,2001.80-81.
  • 3姜文奇 管忠震 林桐榆.肿瘤学[M].北京:人民卫生出版社,1999.320-321.
  • 4Deviaa VT Jr man S,Rosenberg SA.Cancer:principles and pritice of oncology[M].5^th edition.Philadelphia:J B Lippincott,1997:334~336.
  • 5Deviaa VT J,Hell MS,Rosenberg SA.Cancer:principles and pritice of oncology[M].5th edition.Philadelphia:J B Lippincott,1997:334 -336.
  • 6Saioh M,Taguchi,Momose K,et al.Recombinant human interleukin-Ⅱ improved carboplatin-indued thrombocytopenia without affecting antitumor actives in mice bearing Lewis lung carcinoma cells[J].Cancer Chemother Pharmacol,2002,49(2):161.
  • 7Kurzrock R,Cortes J,Thomas DA,et al.Pilot study of lowdose interleukin-Ⅱ in patients with bone marrow failure[J].J Clin Oncol,2001,19(21):4165.
  • 8张斌,蔡玉娥,张齐,英子伟,蒋书玲,徐宏,郑勇学,姜大庆.新辅助化疗用于可手术乳腺癌的10年疗效[J].中国肿瘤临床,2002,29(3):157-159. 被引量:66
  • 9谢瑞祥,范芳,吴国森.反相高效液相色谱法测定紫杉醇浓度及其稳定性考察[J].海峡药学,2003,15(1):29-30. 被引量:8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部